眼筋無力症
- 関
- myasthenia gravis、ocular myasthenia
WordNet
- visible; "be sure of it; give me the ocular proof"- Shakespeare; "a visual presentation"; "a visual image" (同)visual
- of or relating to or resembling the eye; "ocular muscles"; "an ocular organ"; "ocular diseases"; "the optic (or optical) axis of the eye"; "an ocular spot is a pigmented organ or part believed to be sensitive to light" (同)optic, optical, opthalmic
- relating to or using sight; "ocular inspection"; "an optical illusion"; "visual powers"; "visual navigation" (同)optic, optical, visual
- any muscular weakness
PrepTutorEJDIC
- 《文》目の / 《まれ》視覚の,目で見た / (顕微鏡・望遠鏡などの)接眼レンズ,接眼鏡
- 筋無力症
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
- Hurst RL1, Gooch CL2,3.
- Current neurology and neuroscience reports.Curr Neurol Neurosci Rep.2016 Jul;16(7):61. doi: 10.1007/s11910-016-0668-z.
- Autoimmune myasthenia gravis (MG) is the prototypic, antibody-mediated neuromuscular disease and is characterized by a decrease in the number of functional acetylcholine receptors (AChR) within the muscle end plate zone of the neuromuscular junction (NMJ). Although the pathophysiology of AChR-mediat
- PMID 27170368
- Immune-mediated respiratory adverse events of checkpoint inhibitors.
- Tabchi S1, Messier C, Blais N.
- Current opinion in oncology.Curr Opin Oncol.2016 Jul;28(4):269-77. doi: 10.1097/CCO.0000000000000291.
- PURPOSE OF REVIEW: Immune checkpoint inhibitors have demonstrated remarkable efficacy with durable responses in the treatment of various malignancies. This new class of therapeutic agents is associated with a toxicity profile that differs from conventional cytotoxic therapy. The present review is fo
- PMID 27138570
- Myasthenia Gravis Presentation After a Cervical Laminectomy With Fusion.
- Deters D1, Fowler SL, Orozco R, Smith PR, Spurlock S, Blackmon D, Thomas S.
- Dimensions of critical care nursing : DCCN.Dimens Crit Care Nurs.2016 Jul-Aug;35(4):190-4. doi: 10.1097/DCC.0000000000000189.
- Myasthenia gravis is a chronic neuromuscular disorder that causes skeletal muscle weakness. Typically, myasthenia gravis affects the ocular, bulbar, neck, proximal limbs, and respiratory muscles. Although the presentation is typically observed with complaints of vision and bulbar symptoms such as di
- PMID 27258955
Japanese Journal
- 眼筋型重症筋無力症による麻痺性外斜視に対し,上下直筋全幅移動術が有効であった一例
- Quality of life in purely ocular myasthenia in Japan
- 無症候性のBasedow病を合併した自己抗体陰性の眼筋型重症筋無力症の1例 (特集 第67回日本臨床眼科学会講演集(4))
Related Links
- What is ocular myasthenia gravis? Ocular myasthenia gravis is a form of myasthenia gravis (MG) in which the muscles that move the eyes and control the eyelids are easily fatigued and weakened. What are the common symptoms of ...
- Myasthenia gravis (MG) is an autoimmune disorder characterized by weakness and fatigability of skeletal muscles. Muscle weakness due to dysfunction of the neuromuscular junction (myasthenia) may be an acquired disorder, and ...
★リンクテーブル★
[★]
- 英
- ocular myasthenia gravis、ocular myasthenia
- ラ
- myasthenia ocularis
- 関
- 重症筋無力症
[★]
眼筋無力症
- 関
- ocular myasthenia gravis
[★]
- 関
- bulbar、eyeball、eyepiece、globe、optic、vision、visual
[★]
[★]
筋無力症。amyosthenia、myasthenic
[★]
眼筋無力症
- 関
- ocular myasthenia gravis
[★]